Pembrolizumab [KEYTRUDA]

Abbreviation
PEMBRO
Disease(s)
Melanoma, Non-Cell Small Lung cancer, Head & Neck cancer
Background
.pdf
Patent oppositions filed in
India

Pembroliumab drug is a immunotherapy drug used in the treatment of cancer. It is approved for use in various cancers such a melanoma, head & neck cancer and lung cancer.

This drug is missing the following documents, can you help us by contributing something?

Patent Information

Information of patent applications filed at local or international levels, that are contributed by the users of PODB as being relevant to this medicine

Please note that PODB does not provide and guarantee the comprehensive patent landscape in all countries.

*For more knowledge of patent search, please refer to the tutorial Step 2: Patent Search & Analysis
*For more information of the patent landscape on medicines, please also refer to WHO patent landscape reports, UNITAID patent landscape reports, Medicines Patent Pool Patent Status Database

Patent Applications

The table includes information of patent applications as filed in different countries, that are contributed by PODB users as being seen as relevant to this medicine.

CountryFiling datePriority dateApplicantNational numberInternational numberStatusPatent typeMore info
India18-12-2009MERCK SHARP & DOHME B.VIN292137 [7435/CHENP/2009]WO/2008/156712GrantedMoleculesView/Comment
India22-07-2016 PFIZER INC; MERCK SHARP & DOHME LLC201617025251WO/2015/119930A1AbandonedCombinationView/Comment
India16-02-2016MERCK SHARP & DOHME CORP.201647005434WO/2015/026684RejectedCombinationView/Comment
India13-12-2017MERCK SHARP & DOHME B.V201748044868 (Divisional of 7435/CHENP/2009)WO/2008/156712AbandonedMoleculesView/Comment
India29-06-2017MERCK SHARP & DOHME LLC201747022885WO/2016/137850AbandonedSalts and OthersView/Comment
India06-12-2019IMMUNOGEN, INC. ; MERCK SHARP & DOHME LLC201917050541WO/2018/213260AbandonedCombinationView/Comment
India18-10-2019MERCK SHARP & DOHME CORP. ; AMGEN INC.201917042234WO/2018/201028Under ExaminationCombinationView/Comment
India27-04-2021MERCK SHARP & DOHME CORP.202147019387WO/2020/092233Under ExaminationSalts and OthersView/Comment
India22-09-2017MERCK SHARP & DOHME LLC202317075166WO/2016/137985Under ExaminationFormulationsView/Comment
India11-04-2025MERCK SHARP & DOHME LLC202517035691WO/2024/081274Under ExaminationFormulationsView/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top

Oppositions

Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
India19-09-2023RAHUL LAXMAN GAJBHIYE Pre-GrantApplication abandoned by applicantCombination201617025251View/Comment
India14-09-2021 Dr. Priyank PurohitPre-GrantApplication abandoned by applicantCombination201617025251View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top

Patent Office Decisions

This table showcases the final ruling of patent offices over cases where patents have been opposed.

To better identify the case, the number of the patent application is provided in the table below.

Decision typeCountryDatePatent officeRelated patent applicationMore info
AbandonedIndia31-07-2023Indian Patent Office 201747022885View/Comment
RejectionIndia22-07-2021Indian Patent Office 201647005434View/Comment
AbandonedIndia25-11-2024Indian Patent Office 201748044868View/Comment
AbandonedIndia05-07-2024Indian Patent Office 201617025251View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top